EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial

Guozhe Sun, Xiaofan Guo, Guangxiao Li iD, Pengyu Zhang, Yangzhi Yin iD, Lixia Qiao, Ning Ye, Chang Wang iD, Songyue Liu, Danxi Geng iD, Wei Miao, Ziyi Xie und 5 weitere

Journal of the American Heart Association · 2025

DOI: 10.1161/jaha.124.036820 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Guozhe Sun und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology The First Hospital of China Medical University Shenyang China. Hauptthemen laut MEDLINE: Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Blood pressure (BP) management in patients with metabolic syndrome is complex, and optimal targets remain debated. The CRHCP (China Rural Hypertension Control Project) trial demonstrated that intensive BP control reduces cardiovascular events. This secondary analysis assessed its efficacy in patients with hypertension and metabolic syndrome. Methods and Results This a post hoc analysis of a cluster randomized trial (NCT03527719) across 3 Chinese provinces; 18 076 hypertensive patients with metabolic syndrome were followed up for 3 years. Intervention groups received multifaceted BP management by nonphysician health care professionals aiming for

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antihypertensive AgentsBlood PressureCardiovascular DiseasesHypertensionMetabolic SyndromeAgedFemaleHumansMaleMiddle AgedChinaTreatment Outcome

Stichwörter der Autor:innen

cardiovascular diseasesintensive blood pressure strategymetabolic syndrome

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Department of Cardiology The First Hospital of China Medical University Shenyang China.
  • Department of Medical Record Management Center First Hospital of China Medical University Shenyang China.

ORCID-Profile: Guangxiao Li, Yangzhi Yin, Chang Wang, Danxi Geng, Yingxian Sun

Zitieren

APA

Sun, G., Guo, X., Li, G., Zhang, P., Yin, Y., Qiao, L., Ye, N., Wang, C., Liu, S., Geng, D., Miao, W., Xie, Z., Yu, Y., Li, Z., Jiang, X., Tan, X., & Sun, Y. (2025). Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036820

Vancouver

Sun G, Guo X, Li G, Zhang P, Yin Y, Qiao L, et al. Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial. Journal of the American Heart Association. 2025. doi:10.1161/jaha.124.036820

BibTeX
@article{Sun2025,
  author = {Sun, Guozhe and Guo, Xiaofan and Li, Guangxiao and Zhang, Pengyu and Yin, Yangzhi and Qiao, Lixia and Ye, Ning and Wang, Chang and Liu, Songyue and Geng, Danxi and Miao, Wei and Xie, Ziyi and Yu, Yao and Li, Zhi and Jiang, Xiaoqiong and Tan, Xiangyu and Sun, Yingxian},
  title = {Intensive Blood Pressure Strategy on Cardiovascular Diseases in Patients With Metabolic Syndrome: Post Hoc Analysis of a Clinical Trial},
  journal = {Journal of the American Heart Association},
  year = {2025},
  doi = {10.1161/jaha.124.036820}
}
Kostenlos starten →